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The National Health Service Abdominal Aortic Aneurysm Screening Program (NAAASP) has been introduced after
research and analysis of data from a number of randomized trials and existing local screening programs in England that
showed a reduction in aneurysm-related mortality when men aged $65 years were offered ultrasound screening. The
evidence was assessed by the United Kingdom National Screening Committee against a set of internationally recognized
criteria that conﬁrmed that screening all men aged $65 years saves lives. The introduction of abdominal aortic aneurysm
(AAA) screening to men aged 65 years is estimated to reduce premature death from ruptured AAAs by up to 50% over the
next 10 years. This article describes the AAA screening program in England, its ongoing implementation and current
challenges, and outcomes in the ﬁrst 150,000 men. (J Vasc Surg 2013;57:1440-5.)In 2005, the United Kingdom (UK) National
Screening Committee reviewed the evidence for abdominal
aortic aneurysm (AAA) screening in men. In November
2005, it concluded that ultrasound screening should be
offered to men in their 65th year, with men aged >65 years
being able to self-refer within the National Health Service
(NHS). The NHS Abdominal Aortic Aneurysm Screening
Program (NAAASP) was announced by the Department of
Health in January 2008, and in July 2009, the phased
implementation of the program began with screening
taking place in six early implementer sites. It is anticipated
that by April 2013, the service will be fully operational
across England, with w40 local programs offering aneu-
rysm screening to all men in England in the year they
turn 65 (>300,000 new men invited per annum).
EVIDENCE FOR AAA SCREENING
Ruptured AAAs currently cause almost 4000 deaths
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0controlled trials have established that a single abdominal
ultrasound scan in elderly men decreases the risk of aneu-
rysm rupture by almost 50% over the next 10 years.2 Most
AAAs detected by screening are below the threshold of
5.5 cm, where the beneﬁts of intervention are not proven
over conservative management.3 These men undergo ultra-
sound surveillance and receive lifestyle advice that can
reduce the growth rate of small AAAs and minimize cardio-
vascular morbidity. Men with an AAA that enlarges in
surveillance to $5.5 cm are referred for specialist advice
and considered for elective AAA repair.
The largest controlled trial, the Multicentre Aneurysm
Screening Study (MASS)4 showed that a single ultrasound
scan in men aged 65 to 74 years signiﬁcantly reduced the
rate of premature death from AAA rupture. Analysis of the
10-year data concluded that the number of lives saved out-
weighed the number of deaths after elective AAA surgery,
although this effect was waning by 13 years after random-
ization because the number of men with an incidentally
detected AAA rose in the control group.5 A meta-
analysis of all randomized screening trials estimated that
it was necessary to invite 240 men for AAA screening
(with 80% attendance, 192 men scanned) to save one
death from rupture. Conversely, for 2080 men invited
for screening (1660 scanned), there would be one addi-
tional elective surgical death. Over 10 years, for every
10,000 men screened, it was estimated that 52 lives would
be saved but with the risk of six deaths after elective
surgery.2
Screening programs are obliged to inform potential
participants of any possible adverse outcomes. AAA
screening is not without risk, and the program has a small,
but certain risk of death (after elective surgery) for men
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mation leaﬂet sent to all men on invitation.
There are other advantages in having a large AAA
detected by screening. Postoperative mortality after surgery
for men with a screen-detected AAA is lower than in those
with AAAs detected incidentally.6 The reasons for this are
not clear but may include decreased comorbidities, aneu-
rysms that are generally smaller, and aneurysms with
anatomy more amenable to endovascular repair.
SCREENING PATHWAY
The NAAASP standards are based broadly on evidence
from MASS and deﬁned in a standard operating procedure
document that outlines how screening should be delivered
in all localities, to ensure consistency.7 Screening is orga-
nized through local programs, each covering a minimum
population of 800,000, and run by a full-time coordinator,
supervised by a program director, who is a local vascular
specialist. Each year, local screening program centers
receive a list of all men aged 65 in that year in their region
from the national IT system, based on data from family
physicians. The men are sent a written invitation that
includes the standard information leaﬂet and offers an
appointment at a location near their homes. Screening is
done by a mobile team in family doctors’ ofﬁces, NHS
premises, or local hospitals.
Screening is undertaken by screening technicians
trained to a national standard with classroom-based,
E-learning, and on-site skills training that is accredited by
the Consortium for the Accreditation of Sonographic
Education (CASE) and approved by the Society of Radiog-
raphers. The aorta is imaged and the size deﬁned by the
internal anteroposterior aortic diameter in the transverse
plane, using an average of three measurements. The images
are retained for future quality assurance. Men are given
their result immediately and their family physician is
informed. Further information is immediately available
for men with an abnormal aortic scan. Men who fail to
attend are sent a reminder by post; if they fail to attend
on a second occasion, no further action is taken, but their
family physician is informed. The screening process is out-
lined in Fig 1, from invitation to surveillance and treatment
pathways.
IMPLEMENTATION
The NAAASP in England has been implemented over
4 years, in phases (Fig 2). The fourth and ﬁnal phase of
the local programs will be commissioned from October
2012 to April 2013, resulting in planned full coverage of
the country for the 2013 to 2014 cohort of men aged
65 years old. Similar programs are also being implemented
in Scotland, Wales, and Northern Ireland (although all
with separate administration), so that all men in the UK
should have equal access to AAA screening. All vascular
services that receive men with screen-detected AAAs in
England must undergo preimplementation quality assur-
ance to check that they reach standards set by the Vascular
Society of Great Britain and Ireland (VSGBI).UPTAKE AND OUTCOMES
Data from the national NAAASP are held on a bespoke
IT system (AAA SMaRT), which contains details of the call
and recall database, along with all aspects of the screening
pathway and screening outcomes. It links to the VSGBI
National Vascular Database, where registration of proce-
dures and outcomes is mandatory for all surgeons treating
men in NAAASP.
NAAASP has previously published an annual report on
invitations and outcomes for 2009/2010 and 2010/2011.
Analyzing summary data from April 1, 2009, to March 31,
2012, 196,744 men were invited for screening, and
157,730 attended (uptake 80.17%; Table). Overall,
1.57% of scans showed AAAs of $3 cm. Some 2484 men
had a ﬁrst diagnosis of AAA and were invited to enter
the surveillance program. During the ﬁrst 3 years of the
NAAASP, 305 men underwent elective repair of their large
AAA (175 open and 130 endovascular repair). Four deaths
occurred after elective repair #30 days, two in each group
(total mortality, 1.31%). One man who had been screened
in the program had a ruptured AAA. He survived emer-
gency repair of what was found to be a mycotic aneurysm.
CURRENT ISSUES
NAAASP has a formal structure within the NHS,
including a steering group and an advisory group, which
is independent of the program. A number of issues have
arisen during implementation of the national Program.
Vascular service reviews. When the scientiﬁc case was
made for AAA screening, results for elective AAA repair
were published from countries around Europe (VASCU-
NET, 2008).8 Mortality after elective AAA operations in
the UK was 7.5%, double the average for the rest of
Europe. This was a major concern, because the effective-
ness of AAA screening is dependent on the safe manage-
ment of any AAA detected. The VSGBI agreed on an
action plan to set a quality improvement framework con-
sisting of best practice standards for aortic surgery (http://
www.vascularsociety.org.uk/library/quality-improvement.
html). These were approved by VSGBI membership and
used as standards by NAAASP to quality-assure new scr-
eening centers.
The standards set meant that smaller vascular units
needed to coalesce into networks with a single intervention
center, or centralize. The networks are required to have
a single site where inpatient and emergency vascular
services are undertaken but provide a comprehensive
outpatient and day-case service across all the hospitals in
the network. This remodelling of vascular services in the
UK has reduced to w75 the number of sites where aortic
surgery is undertaken and also improved to 2.4% the
30-day mortality after surgery.9
Aortic measurement. NAAASP is predicated on
MASS, which used measurement of a static ultrasound
image of the aorta obtained in the anteroposterior plane,
with a measuring calliper placed on the inner walls of the
aortic image, the inner-to-inner (ITI) method. The
Fig 1. The National Health Service Abdominal Aortic Aneurysm Screening Program (NAAASP) screening process and
pathways are shown for the management of men with normal-sized aortas and those with aortic aneurysms. GP,
General practitioner.
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Fig 2. Map shows the rollout plan of the National Health Service Abdominal Aortic Aneurysm Screening Program
(NAAASP).
Table. National Health Service Abdominal Aortic Aneurysm Screening Program (NAAASP): Initial screening outcomes
2009 to 2012, including annual cohorts plus self-referrals
Year
Initial scans,
No.
Aorta diameter, cm
<3,
No. (%)
3-4.4,
No. (%)
4.5-5.4,
No. (%)
$5.5,
No. (%)
Total $3,
No. (%)
2009-10 23,696 23,292 (98.30) 330 (1.39) 30 (0.13) 44 (0.19) 404 (1.70)
2010-11 35,380 34,766 (98.26) 503 (1.42) 66 (0.19) 45 (0.13) 614 (1.74)
2011-12 98,654 97,188 (98.51) 1157 (1.17) 168 (0.17) 141 (0.14) 1466 (1.49)
2009-12 157,730 155,246 (98.43) 1990 (1.26) 264 (0.17) 230 (0.15) 2484 (1.57)
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rysm. Many vascular laboratories place the callipers on the
outer wall of the aorta (outer-to-outer), thus including the
thickness of the aorta, which may be several millimeters
bigger.
A recent study using NAAASP technicians and more
experienced technologists suggested that reliability is
greater with ITI.10 The ITI method gives the lowest
possible measurement of aortic diameter, which has impli-
cations for screened men whose aortic diameter ismeasured just <3 cm at the age of 65, who will be reas-
sured and discharged. Another group potentially disadvan-
taged is men with an aortic diameter of 5.2 to 5.4 cm in
surveillance whose referral for surgery may be delayed.
Research is ongoing into the implications for these men.
It is probably more important that standard methodology
is used than which technique is used.
Cost-effectiveness of AAA screening. The epidemi-
ology of AAAs appears to be changing.1 The prevalence
of aortic diameter >29 mm was about 4% in MASS,4 and
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this rate. In the ﬁrst 3 years of NAAASP, the detection rate
was just under 1.6%, although this was effectively based
only on a sample of w40% of the population. In similar
contemporary studies from New Zealand,11 Sweden,12 and
Gloucestershire, UK,13 the decreasing prevalence of AAAs
has also been observed. Perhaps this is not surprising,
because there is good evidence of a global reduction
in cardiovascular disease in many Western populations,
together with the rise in diabetes, which may be protective.
Changes in diet and lifestyle, reductions in smoking habits,
and general application of preventive treatments for
hypertension and hypercholesterolemia are all likely to
have contributed.14 This questions the potential cost-
effectiveness of any future national AAA screening
programs. The initial calculations done using data from
MASS suggested that the incremental cost-effectiveness
ratio was £7600/life-year gained, within the accepted
range in most modern health systems.4 Early estimation
from England and other European countries is that AAA
screening, as presently described, may remain cost-
effective, with incidence rates as low as 1%.15
There are cost differences between open and endovas-
cular surgery for AAAs. Some men with screen-detected
AAAs will have an anatomy that is not suitable for infrare-
nal bifurcated stent grafts and may require fenestrated
or branched devices. This will have signiﬁcant cost implica-
tions for the NHS, both for the surgery and ongoing
surveillance after stent graft insertion.
IMPROVING EFFICIENCY
During implementation of NAAASP, there has been
intense scrutiny of early results. A number of research
groups have made proposals about how AAA screening
programs might develop. The reducing prevalence of
AAAs at age 65 has led to the suggestion that the age of
invitation should be raised to 68 or even 70 years. This
would increase yield but would also have the effect of
missing some younger men who would die from AAA
rupture.
The aortic diameter for entering surveillance (3 cm) is
somewhat arbitrary, and mature screening programs have
observed that men with an aortic diameter just below
3 cm also have a signiﬁcant risk of developing a large
AAA, although it is not known how many of these
would have ruptured without treatment.16 Men with
a subthreshold aorta at 65 (range, 2.5-2.9 cm) are also at
increased risk of cardiovascular complications.17 Potential
strategies range from including men with subthreshold
aortic diameter in screening surveillance to simply inform-
ing them and their family physician that they are at risk, so
that medical treatment may be optimized. The increasing
amount of data on men with small AAAs under surveillance
has enabled calculations of optimal intervals between
surveillance scans; a saving here might allow inclusion of
men with a subthreshold aortic diameter at no extra overall
cost.18 There is also the complex issue of rescreening and
whether repeating an ultrasound scan after 5 or 10 yearscould increase the yield; recent theoretic modelling
suggests this may be cost-effective.19
Finally, there remains the charge that only screening
men is disadvantageous to women, despite previous
research that clearly shows screening women aged 65 to
74 was not cost-effective.20 There is some evidence that
the decline in AAA prevalence is less in women than
men.1 However, the most recent population data from
Sweden suggest that AAAs are now rare in nonsmokers,
so population screening is inefﬁcient for women.21
CONCLUSIONS
NAAASP is a new population-screening program and
will continue to evolve. It is noteworthy that to date, there
has been a lower prevalence of AAAs in 65-year-old men
than expected from the literature and lower than in the
AAA screening program in America.22 A recent publica-
tion5 has suggested that AAA screening will remain cost-
effective even at an incidence rate of 1%. A formal updated
cost beneﬁt analysis for AAA screening in the UK is
currently being undertaken, and it is anticipated that this
will help to formulate aneurysm-screening protocols in
the future. NAAASP is on target to implement aneurysm
screening to all men aged 65 years resident in England
by April 2013. In the meantime, a formal decision has
been made to adhere to the same protocols and standards
during implementation. In the longer term, to be effective,
the NAAASP will need to be responsive to research as it
emerges.
We are grateful for the enthusiasm and support of all
the local AAA screening program teams. Full details of
the NHS AAA Screening Program can be found on the
Web site at http://aaa.screening.nhs.uk.
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